StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3057% below fair value
$0.41−0.03 (-7.45%)

Close on Nov 20, 2026Market cap $121.65MP/E –Yield –

Invivyd shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Invivyd's shares outstanding was 320M at Jun 30, 2026. For fiscal 2025 it was 172M, up 45.3% from the year before. The highest annual figure on record is 172M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025172M+45.3%
FY2024Dec 31, 2024119M+8.2%
FY2023Dec 31, 2023110M+1.2%
FY2022Dec 31, 2022108M+154.0%
FY2021Dec 31, 202143M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026320M+167.0%
Q1 FY2026Mar 31, 2026310M+158.3%
Q4 FY2025Dec 31, 2025278M+132.4%
Q3 FY2025Sep 30, 2025170M+42.4%
Q2 FY2025Jun 30, 2025120M+0.5%
Q1 FY2025Mar 31, 2025120M+3.7%
Q4 FY2024Dec 31, 2024120M+8.7%
Q3 FY2024Sep 30, 2024119M+8.9%
Q2 FY2024Jun 30, 2024119M+9.1%
Q1 FY2024Mar 31, 2024116M+6.3%
Q4 FY2023Dec 31, 2023110M+1.4%
Q3 FY2023Sep 30, 2023110M+1.2%
Q2 FY2023Jun 30, 2023109M+1.2%
Q1 FY2023Mar 31, 2023109M+0.8%
Q4 FY2022Dec 31, 2022109M+1.0%
Q3 FY2022Sep 30, 2022108M+76.9%
Q2 FY2022Jun 30, 2022108M+43206.8%
Q1 FY2022Mar 31, 2022108M–
Q4 FY2021Dec 31, 2021108M+5720.4%
Q3 FY2021Sep 30, 202161M–
Q2 FY2021Jun 30, 20210M–
Q1 FY2021Mar 31, 20210M–
Q3 FY2020Sep 30, 20202M–

More Invivyd figures

See a number that looks wrong?